These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21597485)

  • 21. One year results of anti-VEGF treatment in pigment epithelial detachment secondary to macular degeneration.
    Yüksel H; Türkcü FM; Sahin A; Sahin M; Cinar Y; Cingü AK; Ari S; Caça I
    Arq Bras Oftalmol; 2013; 76(4):209-11. PubMed ID: 24061828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment
    Witkin AJ; Rayess N; Garg SJ; Maguire JI; Storey P; Kaiser RS; Hsu J; Vander JF; Ho AC
    Semin Ophthalmol; 2017; 32(3):309-315. PubMed ID: 26337539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal ranibizumab for pigment epithelium detachment with subfoveal occult choroidal neovascularization: a prospective 24-month case series.
    Parodi MB; Iacono P; Papayannis A; Kontadakis SD; Cascavilla M; Pierro L; Gagliardi M; Bandello F
    Am J Ophthalmol; 2013 Jan; 155(1):103-108.e2. PubMed ID: 23022164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinal pigment epithelial tears following ranibizumab therapy for fibrovascular retinal pigment epithelial detachment due to occult age-related macular degeneration.
    Figurska M
    Med Sci Monit; 2012 Jan; 18(1):CR32-38. PubMed ID: 22207117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AFLIBERCEPT AFTER RANIBIZUMAB INTRAVITREAL INJECTIONS IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: The ARI2 Study.
    Blanco-Garavito R; Jung C; Uzzan J; Quaranta-ElMaftouhi M; Coscas F; Sahel J; Korobelnik JF; Béchet S; Querques G; Souied EH
    Retina; 2018 Dec; 38(12):2285-2292. PubMed ID: 29190241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WRINKLED VASCULARIZED RETINAL PIGMENT EPITHELIUM DETACHMENT PROGNOSIS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
    Lam D; Semoun O; Blanco-Garavito R; Jung C; Nguyen DT; Souied EH; Mimoun G
    Retina; 2018 Jun; 38(6):1100-1109. PubMed ID: 28520639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD.
    Gutfleisch M; Heimes B; Schumacher M; Dietzel M; Lommatzsch A; Bird A; Pauleikhoff D
    Eye (Lond); 2011 Sep; 25(9):1181-6. PubMed ID: 21701525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of eyes with secondary loss of visual acuity receiving variable dosing ranibizumab for neovascular age-related macular degeneration.
    Mariani A; Deli A; Ambresin A; Mantel I
    Graefes Arch Clin Exp Ophthalmol; 2011 Nov; 249(11):1635-42. PubMed ID: 21725716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between macular structure and function in patients with age-related macular degeneration treated with intravitreal ranibizumab: 12-month-results.
    Nishimura T; Machida S
    Jpn J Ophthalmol; 2019 Jan; 63(1):90-99. PubMed ID: 30470956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment.
    Weinberger AW; Thiel M; Mohammadi B; Theofylaktopoulos I; Thumann G; Walter P
    Am J Ophthalmol; 2007 Aug; 144(2):294-6. PubMed ID: 17659961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OUTCOME OF INTRAVITREAL AFLIBERCEPT FOR REFRACTORY PIGMENT EPITHELIAL DETACHMENT WITH OR WITHOUT SUBRETINAL FLUID AND SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Kim K; Kim ES; Kim Y; Yang JH; Yu SY; Kwak HW
    Retina; 2019 Feb; 39(2):303-313. PubMed ID: 29160779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of Change in Pigment Epithelial Detachment Volume and Morphology After Transition to Intravitreal Aflibercept in Eyes With Recalcitrant Neovascular AMD: 18-Month Results.
    Kanesa-Thasan A; Grewal DS; Gill MK; Lyon AT; Mirza RG
    Ophthalmic Surg Lasers Imaging Retina; 2015 Jun; 46(6):638-41. PubMed ID: 26114844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bevacizumab simultaneous combined with dexamethasone implant for treatment of neovascular serous retinal pigment epithelial detachment secondary to neovascular age-related macular degeneration.
    Limon U; Sezgin Akcay BI
    Eur J Ophthalmol; 2022 Sep; 32(5):NP32-NP36. PubMed ID: 33781113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GOOD VISUAL OUTCOME AT 1 YEAR IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH PIGMENT EPITHELIUM DETACHMENT: Factors Influencing the Treatment Response.
    de Massougnes S; Dirani A; Mantel I
    Retina; 2018 Apr; 38(4):717-724. PubMed ID: 28368974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-year course of subfoveal pigment epithelial detachment in eyes with age-related macular degeneration and visual acuity better than 20/40.
    Baba T; Kitahashi M; Kubota-Taniai M; Oshitari T; Yamamoto S
    Ophthalmologica; 2012; 228(2):102-9. PubMed ID: 22508168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab.
    Patel KH; Chow CC; Rathod R; Mieler WF; Lim JI; Ulanski LJ; Leiderman YI; Arun V; Chau FY
    Eye (Lond); 2013 May; 27(5):663-7; quiz 668. PubMed ID: 23558214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of neovascular age-related macular degeneration with a variable ranibizumab dosing regimen and one-time reduced-fluence photodynamic therapy: the TORPEDO trial at 2 years.
    Spielberg L; Leys A
    Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):943-56. PubMed ID: 20204659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of intravitreal ranibizumab in avascular pigment epithelial detachment.
    Ritter M; Bolz M; Sacu S; Deák GG; Kiss C; Pruente C; Schmidt-Erfurth UM
    Eye (Lond); 2010 Jun; 24(6):962-8. PubMed ID: 19911018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth U; Waldstein SM; Deak GG; Kundi M; Simader C
    Ophthalmology; 2015 Apr; 122(4):822-32. PubMed ID: 25578255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
    Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
    Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.